EGFR and psoriasis: Experiments performed in HaCaT human keratinocyte cell line treated with sodium butyrate and an inhibitor of epidermal growth factor receptor showed enhanced keratinocyte differentiation suggesting this combination as a potential tool in the treatment of hyperproliferative skin diseases including psoriasis [114].